Treatment of IgA nephropathy in children
- PMID: 7917875
- DOI: 10.1007/BF00866376
Treatment of IgA nephropathy in children
Comment on
-
Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisone.Pediatr Nephrol. 1993 Oct;7(5):529-32. doi: 10.1007/BF00852535. Pediatr Nephrol. 1993. PMID: 8251315
Similar articles
-
Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisone.Pediatr Nephrol. 1993 Oct;7(5):529-32. doi: 10.1007/BF00852535. Pediatr Nephrol. 1993. PMID: 8251315
-
Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.Am J Kidney Dis. 2017 Jun;69(6):788-795. doi: 10.1053/j.ajkd.2016.11.027. Epub 2017 Feb 16. Am J Kidney Dis. 2017. PMID: 28215945 Clinical Trial.
-
Effect of camostat mesilate on persistent proteinuria of IgA nephropathy.Nephron. 1992;60(2):244-5. doi: 10.1159/000186752. Nephron. 1992. PMID: 1553016 No abstract available.
-
[Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].G Ital Nefrol. 2002 Sep-Oct;19(5):523-8. G Ital Nefrol. 2002. PMID: 12439840 Review. Italian.
-
An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism.Am J Kidney Dis. 2003 Jun;41(6):1129-39. doi: 10.1016/s0272-6386(03)00344-5. Am J Kidney Dis. 2003. PMID: 12776264 Review.
Cited by
-
Re-evaluation of phosphoric acid-phosphates - di-, tri- and polyphosphates (E 338-341, E 343, E 450-452) as food additives and the safety of proposed extension of use.EFSA J. 2019 Jun 12;17(6):e05674. doi: 10.2903/j.efsa.2019.5674. eCollection 2019 Jun. EFSA J. 2019. PMID: 32626329 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous